Beesley et al identified risk factors for lymphedema of the lower extremities in women following therapy for gynecological cancer. These can help identify women who may require closer monitoring and more aggressive management. The authors are from the Queensland University of Technology, University of Queensland, and Royal Brisbane & Women's Hospital in Australia.